-
1
-
-
33746336533
-
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology
-
DOI 10.1111/j.0105-2896.2006.00419.x
-
Sansom DM, Walker LS. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev. 2006;212:131-148. doi:10.1111/j.0105-2896.2006.00419.x. (Pubitemid 44116705)
-
(2006)
Immunological Reviews
, vol.212
, pp. 131-148
-
-
Sansom, D.M.1
Walker, L.S.K.2
-
2
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
-
doi:10.1126/science.270.5238.985
-
Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270:985-988. doi:10.1126/science.270.5238.985.
-
(1995)
Science
, vol.270
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
-
3
-
-
36849035139
-
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): A novel strategy for the treatment of melanoma and other malignancies
-
DOI 10.1002/cncr.23086
-
O'Day SJ, Hamid O, Urba WJ. Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): A novel strategy for the treatment of melanoma and other malignancies. Cancer. 2007;110:2614-2627. doi:10.1002/cncr.23086. (Pubitemid 350250330)
-
(2007)
Cancer
, vol.110
, Issue.12
, pp. 2614-2627
-
-
O'Day, S.J.1
Hamid, O.2
Urba, W.J.3
-
4
-
-
27844458057
-
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: A phase I/II study
-
DOI 10.1245/ASO.2005.03.536
-
Maker AV, Phan GQ, Attia P, et al. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyteassociated antigen 4 blockade and interleukin 2: A phase I/II study. Ann Surg Oncol. 2005;12:1005-1016. doi:10.1245/ASO.2005.03.536. (Pubitemid 41660676)
-
(2005)
Annals of Surgical Oncology
, vol.12
, Issue.12
, pp. 1005-1016
-
-
Maker, A.V.1
Phan, G.Q.2
Attia, P.3
Yang, J.C.4
Sherry, R.M.5
Topalian, S.L.6
Kammula, U.S.7
Royal, R.E.8
Haworth, L.R.9
Levy, C.10
Kleiner, D.11
Mavroukakis, S.A.12
Yellin, M.13
Rosenberg, S.A.14
-
5
-
-
0038153907
-
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
-
DOI 10.1073/pnas.1533209100
-
Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003;100:8372-8377. doi:10.1073/pnas.1533209100. (Pubitemid 36842552)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.14
, pp. 8372-8377
-
-
Phan, G.Q.1
Yang, J.C.2
Sherry, R.M.3
Hwu, P.4
Topalian, S.L.5
Schwartzentruber, D.J.6
Restifo, N.P.7
Haworth, L.R.8
Seipp, C.A.9
Freezer, L.J.10
Morton, K.E.11
Mavroukakis, S.A.12
Duray, P.H.13
Steinberg, S.M.14
Allison, J.P.15
Davis, T.A.16
Rosenberg, S.A.17
-
6
-
-
20044395957
-
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma
-
DOI 10.1200/JCO.2005.01.128
-
Sanderson K, Scotland R, Lee P, et al. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. J Clin Oncol. 2005;23:741-750. doi:10.1200/JCO.2005. 01.128. (Pubitemid 46224173)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.4
, pp. 741-750
-
-
Sanderson, K.1
Scotland, R.2
Lee, P.3
Liu, D.4
Groshen, S.5
Snively, J.6
Sian, S.7
Nichol, G.8
Davis, T.9
Keler, T.10
Yellin, M.11
Weber, J.12
-
7
-
-
33744792341
-
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
-
DOI 10.1200/JCO.2005.04.5716
-
Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyteassociated antigen 4. J Clin Oncol. 2006;24:2283-2289. doi: 10.1200/JCO.2005.04.5716. (Pubitemid 46630658)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.15
, pp. 2283-2289
-
-
Beck, K.E.1
Blansfield, J.A.2
Tran, K.Q.3
Feldman, A.L.4
Hughes, M.S.5
Royal, R.E.6
Kammula, U.S.7
Topalian, S.L.8
Sherry, R.M.9
Kleiner, D.10
Quezado, M.11
Lowy, I.12
Yellin, M.13
Rosenberg, S.A.14
Yang, J.C.15
-
8
-
-
37349072460
-
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis
-
DOI 10.1097/CJI.0b013e318156e47e, PII 0000237120071100000005
-
Yang JC, Hughes M, Kammula U, et al. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother. 2007;30: 825-830. doi:10.1097/CJI.0b013e318156e47e. (Pubitemid 350295361)
-
(2007)
Journal of Immunotherapy
, vol.30
, Issue.8
, pp. 825-830
-
-
Yang, J.C.1
Hughes, M.2
Kammula, U.3
Royal, R.4
Sherry, R.M.5
Topalian, S.L.6
Suri, K.B.7
Levy, C.8
Allen, T.9
Mavroukakis, S.10
Lowy, I.11
White, D.E.12
Rosenberg, S.A.13
-
9
-
-
33847407907
-
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
-
DOI 10.1158/1078-0432.CCR-06-1974
-
O'Mahony D, Morris JC, Quinn C, et al. A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res. 2007;13:958-964. doi:10.1158/1078-0432.CCR-06-1974. (Pubitemid 46340373)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.3
, pp. 958-964
-
-
O'Mahony, D.1
Morris, J.C.2
Quinn, C.3
Gao, W.4
Wilson, W.H.5
Gause, B.6
Pittaluga, S.7
Neelapu, S.8
Brown, M.9
Fleisher, T.A.10
Gulley, J.L.11
Schlom, J.12
Nussenblatt, R.13
Albert, P.14
Davis, T.A.15
Lowy, I.16
Petrus, M.17
Waldmann, T.A.18
Janik, J.E.19
-
10
-
-
34250223096
-
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
-
DOI 10.1158/1078-0432.CCR-06-2318
-
Small EJ, Tchekmedyian NS, Rini BI, Fong L, Lowy I, Allison JP. A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Clin Cancer Res. 2007;13:1810-1815. doi:10.1158/1078-0432.CCR-06-2318. (Pubitemid 46952950)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.6
, pp. 1810-1815
-
-
Small, E.J.1
Tchekmedyian, N.S.2
Rini, B.I.3
Fong, L.4
Lowy, I.5
Allison, J.P.6
-
11
-
-
0034679567
-
+ regulatory cells that control intestinal inflammation
-
DOI 10.1084/jem.192.2.295
-
Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295-302. doi:10.1084/jem.192.2.295. (Pubitemid 30470312)
-
(2000)
Journal of Experimental Medicine
, vol.192
, Issue.2
, pp. 295-302
-
-
Read, S.1
Malmstrom, V.2
Powrie, F.3
-
12
-
-
0034679560
-
+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
-
DOI 10.1084/jem.192.2.303
-
Takahashi T, Tagami T, Yamazaki S, et al. Immunologic selftolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-310. doi:10.1084/jem.192.2.303. (Pubitemid 30470313)
-
(2000)
Journal of Experimental Medicine
, vol.192
, Issue.2
, pp. 303-309
-
-
Takahashi, T.1
Tagami, T.2
Yamazaki, S.3
Uede, T.4
Shimizu, J.5
Sakaguchi, N.6
Mak, T.W.7
Sakaguchi, S.8
-
13
-
-
0035806290
-
+ T cells with regulatory properties isolated from peripheral blood
-
DOI 10.1084/jem.193.11.1285
-
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294. doi: 10.1084/jem.193.11.1285. (Pubitemid 32524778)
-
(2001)
Journal of Experimental Medicine
, vol.193
, Issue.11
, pp. 1285-1294
-
-
Jonuleit, H.1
Schmitt, E.2
Stassen, M.3
Tuettenberg, A.4
Knop, J.5
Enk, A.H.6
-
14
-
-
33749132564
-
+ regulatory T cells abrogates their function in vivo
-
+ regulatory T cells abrogates their function in vivo. J Immunol. 2006;177:4376-4383.
-
(2006)
J Immunol
, vol.177
, pp. 4376-4383
-
-
Read, S.1
Greenwald, R.2
Izcue, A.3
-
15
-
-
4444369694
-
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse
-
DOI 10.1016/j.immuni.2004.06.017, PII S1074761304002109
-
Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 2004;21:401-413. doi:10.1016/j.immuni.2004.06.017. (Pubitemid 39208341)
-
(2004)
Immunity
, vol.21
, Issue.3
, pp. 401-413
-
-
Pentcheva-Hoang, T.1
Egen, J.G.2
Wojnoonski, K.3
Allison, J.P.4
-
16
-
-
0018830241
-
The diagnostic accuracy of the rectal biopsy in acute graft-versushost disease: A prospective study of thirteen patients
-
Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versushost disease: A prospective study of thirteen patients. Gastroenterology. 1980;78:764-771.
-
(1980)
Gastroenterology
, vol.78
, pp. 764-771
-
-
Epstein, R.J.1
McDonald, G.B.2
Sale, G.E.3
Shulman, H.M.4
Thomas, E.D.5
|